期刊文献+

^(18)F-FDG PET显像在胰腺癌诊断中的临床应用 被引量:2

The clinical application of ^(18) F-FDG PET imaging for diagnosis of pancreas cancer
暂未订购
导出
摘要 目的 :探讨18F FDGPET显像在胰腺癌诊断中的应用价值。方法 :5 4例临床怀疑为胰腺癌的患者均行18F FDGPET显像 ,对显像结果进行目测法及半定量分析 ,并与CT、手术、腹腔镜取病理等进行对比研究。结果 :18F FDGPET显像对胰腺癌诊断的敏感度为 93 % ( 3 8/4 1) ,特异度为 85 % ( 11/13 )。CT对胰腺癌诊断的敏感度为 76% ( 3 1/4 1) ,特异度为 69% ( 9/13 )。18F FDGPET显像发现 7例CT检查未能确定的肝、肺及淋巴结转移 ,同时PET诊断结果使 15例( 2 8% )患者的临床治疗方案得到修正。结论 :18F FDGPET显像对胰腺癌的诊断及临床分期具有较好的临床应用价值。 Objective:To assess the value of 18 F-2-fluoro-2-deoxy-d-glucose (FDG) PET in the diagnosis of pancreas cancer. Methods: 18 F-FDG PET was performed in fifty-four patients who presented with clinical signs of suspected pan- creatic carcinoma.Imaging findings were analysed with semiquantitative method and correlated with other imaging techniques,surgery and pathology by celioiscope.Results:PET had a sensitivity of 93% (38/41) and a specificity of 85% (11/13) in detecting pancreas cancer in 54 patients,while CT had 76% (31/41) and 69% (9/13) respectively. 18 F-FDG PET found metastasis of liver,lung and lymph nodes which were not detected with CT in 7 cases.According to the results of PET scan,the clinical decision of treatment had been corrected in fifteen patients (28%) .Conclusion: 18 F-FDG PET is a very useful modality for diagnosis and clinical staging of pancreas cancer.
出处 《放射学实践》 2004年第4期295-297,共3页 Radiologic Practice
关键词 ^18F-FDGPET显像 胰腺癌 影像学诊断 临床分期 肿瘤转移 Pancreas neoplasms Tomography,emission-computed Deoxyglucose
  • 相关文献

参考文献4

  • 1Friederike C. Rau,Wolfgang A. Weber,Hans-Jürgen Wester,Michael Herz,Ingrid Becker,Achim Krüger,Markus Schwaiger,Reingard Senekowitsch-Schmidtke. O-(2-[18F]Fluoroethyl)-L-tyrosine (FET): a tracer for differentiation of tumour from inflammation in murine lymph nodes[J] 2002,European Journal of Nuclear Medicine and Molecular Imaging(8):1039~1046
  • 2Achim H. Kaim,Bruno Weber,Michael O. Kurrer,Gerrit Westera,Alain Schweitzer,Jochen Gottschalk,Gustav K. von Schulthess,Alfred Buck. 18F-FDG and 18F-FET uptake in experimental soft tissue infection[J] 2002,European Journal of Nuclear Medicine and Molecular Imaging(5):648~654
  • 3Michael Zimny,Roland Bares,Jürgen Fa?,Gerhard Adam,Uwe Cremerius,Bernhard Dohmen,Peter Klever,Osama Sabri,Volker Schumpelick,Udalrich Buell. Fluorine-18 fluorodeoxyglucose positron mission tomography in the differential diagnosis of pancreatic carcinoma: a report of 106 cases[J] 1997,European Journal of Nuclear Medicine(6):678~682
  • 4Takashi Kato,Hiroshi Fukatsu,Kengo Ito,Masanori Tadokoro,Toyohiro Ota,Mitsuru Ikeda,Takayuki Isomura,Shigeki Ito,Masanari Nishino,Takeo Ishigaki. Fluorodeoxyglucose positron emission tomography in pancreatic cancer: an unsolved problem[J] 1995,European Journal of Nuclear Medicine(1):32~39

同被引文献27

  • 1王中秋,卢光明,郑玲,朱虹,常林风,吴江,秦莉萍.PET/CT及其他影像手段对胰腺癌诊断的比较研究[J].医学影像学杂志,2006,16(1):84-87. 被引量:17
  • 2王中秋,卢光明,朱虹,常林风,吴江,郑玲,王俊鹏,秦莉萍.胰腺癌^(18)F-脱氧葡萄糖PET/CT的影像表现及其诊断价值[J].医学研究生学报,2006,19(4):359-361. 被引量:18
  • 3陈英鑫,李苏建,王中秋.胰腺癌多层螺旋CT成像新进展[J].中国医学影像技术,2006,22(11):1767-1770. 被引量:10
  • 4Singer E, Gschwantler M, Plattner D, et al. Differential diagnosis of benign and malign pancreatic masses with ^18F-fluordeoxyglucosepositron emission tomography recorded with a dual-head coincidence gamma camera [J]. Eur J Gastroenterol Hepatol,2007,19 (6) :471 - 478.
  • 5Mansour J C, Schwartz L, Pandit-Taskar N, et al. The utility of F- 18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas [J]. J Gastrointest Surg, 2006,10(10) : 1354-1360.
  • 6Ruf J, Lopez-Hanninen E, Bohmig M et al. Impact of FDG-PET/ MRI image fusion on the detection of pancreatic cancer [J]. Pancreatology, 2006,6 ( 6 ) : 512-519.
  • 7Bang S, Chung H W, Park S W, et al. The clinical usefulness of 18-fluorodeoxyglucose positron differential diagnosis, staging, emission tomography in the and response evaluation after concurrent chemoradiotherapy for pancreatic cancer Gastroenterol, 2006,40(10) : 923-929.
  • 8Heinrich S, Goerres G W, Schafer M, et al. Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness [J]. Ann Surg, 2005,242 ( 2 ) : 235-243.
  • 9Lytras D, Connor S, Bosonnet L, et al. Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer [J ]. Dig Surg, 2005,22 (1-2) : 55-61.
  • 10Sperti C, Pasquali C, Decet G, et al. F- 18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study [J ]. J Gastrointest Surg, 2005,9 ( 1 ) : 22-28.

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部